Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
ESMO Open|July 5, 2021
Sacituzumab govitecan and trastuzumab deruxtecan: two new antibody-drug conjugates in the breast cancer treatment landscapeE Adams, H Wildiers, P Neven, et al.
Breast Cancer Research and Treatment|January 16, 2021
Scalp cooling in breast cancer patients treated with docetaxel-cyclophosphamide: patient- and nurse-reported resultsA Coolbrandt, A T'Jonck, K Blauwens, et al.
Breast Cancer Research and Treatment|January 4, 2022
Preventing taxane-related peripheral neuropathy, pain and nail toxicity: a prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast cancerAnnemarie Coolbrandt, K Vancoille, E Dejaeger, et al.
Breast Cancer Research and Treatment|September 27, 2020
Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancerElisa Van Raemdonck, G Floris, P Berteloot, et al.
ESMO Open|July 16, 2021
Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3L De Cock, J Heylen, A Wildiers, et al.
Breast Cancer Research and Treatment|May 9, 2019
Intra-arterial Mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survivalB M Aarts, E G Klompenhouwer, R C Dresen, et al.
ESMO Open|July 17, 2021
Assessment of potential process quality indicators for systemic treatment of breast cancer in Belgium: a population-based studyL van Walle, K Punie, E Van Eycken, et al.
Breast Cancer Research and Treatment|May 17, 2018
Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancerG Hoste, K Punie, H Wildiers, et al.
ESMO Open|March 13, 2025
Oncology professionals' perceptions and recommendations to improve well-being and health at work in times of crisis: qualitative thematic analysis from the ESMO Resilience Task Force survey seriesC Hardy, E Thorne, M O'Connor, et al.
ESMO Open|September 6, 2024
Real-world treatment patterns and outcomes in patients with HR+/HER2- metastatic breast cancer treated with chemotherapy in the United StatesS M Tolaney, K Punie, L A Carey, et al.
Pageof 3